Archives for October 20, 2015

CPhI Worldwide 2015

Profile of a CEO: Piramal Chief shares M&A plans

Piramal chief executive Vivek Sharma won last week’s CPhI award for the pharma industry’s CEO of the year. Outsourcing-Pharma.com spoke to Sharma about his plans for the CDMO the day after the jury’s unanimous decision.

Pharmerging markets will be a $500bn 'game changer,' says Reva

‘Pharmerging markets’ have extended beyond Brazil, Russia, India and China (BRIC) and will be worth $500bn by 2020, according to Reva Pharma.

CPhI Worldwide 2015

After the M&A bubble bursts: the four types of pharma firm to survive

An advisor to the pharma industry on M&A says the current boom in pharma valuations will not last, and R&D cost pressures will reshape firms of the future.

Sanofi actions hiring freeze on back of poor Afrezza performance, ex-sales rep claims

Sanofi has reportedly issued a hiring freeze across its commercial team for its inhaled insulin product, Afrezza.

Syngene eyes capacity and capability expansion post-IPO

Syngene says it will invest in new capacity and capabilities, including a viral testing facility, as it reports strong results in its first quarter post-IPO.